Retraction
MicroRNA‑381 serves as a prognostic factor and inhibits migration and invasion in non‑small cell lung cancer by targeting LRH‑1
Paper Information
Record ID:
48071
Author(s):
Journal:
Publication Date:
September 14, 2017
Retraction Date:
October 02, 2023
(2.1 years years ago)
Subjects:
Institutions:
- Department of Oncology, Cangnan Hospital Affiliated to Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China
- Tumor Department of Hematology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China
- Department of Oncology, Zhejiang Tumor Hospital, Hangzhou, Zhejiang 310000, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/or.2023.8640Additional Notes:
see also: https://pubpeer.com/publications/D254E1BEC135EDF97109B0E953ADB5
Citations (17)
17
Total Citations1
Post-Retraction(5.9%)
16
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
178
Days since retraction (latest)
NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score
Liusheng Wu, Xiaofan Chen, Qi Zeng et al. (8 authors)
Heliyon
Open Access
Published: Mar 2024
38 citations
38 citations
178 days after retraction
CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
Jinfang Su, Yongbiao Huang, Yali Wang et al. (7 authors)
Cancer Cell International
Open Access
Published: Feb 2022
8 citations
8 citations
600 days before retraction
MicroRNA‐381 in human cancer: Its involvement in tumour biology and clinical applications potential
Huanhuan Sha, Yujie Gan, Feng Xu et al. (10 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Jan 2022
9 citations
9 citations
629 days before retraction
LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer
Mingkun Zhang, Liu Yang, Lan Hou et al. (4 authors)
Bioengineered
Open Access
Published: Nov 2021
33 citations
33 citations
679 days before retraction
miR-381-3p suppresses breast cancer progression by inhibition of epithelial–mesenchymal transition
Yong-Zheng Yu, Qiang Mu, Qian Ren et al. (6 authors)
World Journal of Surgical Oncology
Open Access
Published: Aug 2021
20 citations
20 citations
787 days before retraction
NR5A2 and potential regulatory miRNAs in the bovine CL during early pregnancy
Camilla H K Hughes, A Rogus, E. K. Inskeep et al. (4 authors)
Reproduction
Open Access
Published: Dec 2020
10 citations
10 citations
1021 days before retraction
MicroRNA-381—A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer
Xue Zeng, Zhe Cao, Wenhao Luo et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Nov 2020
8 citations
8 citations
1040 days before retraction
Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia
Piqiang Zhang, Deyun Sun, Xuemei Sun et al. (4 authors)
European journal of medical research
Open Access
Published: Sep 2020
5 citations
5 citations
1111 days before retraction
Nuclear‐mitochondrial crosstalk: On the role of the nuclear receptor liver receptor homolog‐1 (<scp>NR5A2</scp>) in the regulation of mitochondrial metabolism, cell survival, and cancer
Svenja Michalek, Thomas Brunner
IUBMB Life
Open Access
Published: Sep 2020
20 citations
20 citations
1112 days before retraction
<p>SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381</p>
Hailong Mi, Xiaochun Wang, Fang Wang et al. (8 authors)
OncoTargets and Therapy
Open Access
Published: Jan 2020
32 citations
32 citations
1370 days before retraction
<p>EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression</p>
Dongwei Dou, Xin Ge, Xinxing Wang et al. (9 authors)
OncoTargets and Therapy
Open Access
Published: Nov 2019
32 citations
32 citations
1431 days before retraction
MicroRNA in Lung Cancer Metastasis
Shang‐Gin Wu, Tzu‐Hua Chang, Yinan Liu et al. (4 authors)
Cancers
Open Access
Published: Feb 2019
69 citations
69 citations
1682 days before retraction
miR‑381 and miR‑489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/β‑catenin pathway in gastric cancer
Ziling Fang, Min Zhong, Yi Wang et al. (10 authors)
International Journal of Oncology
Open Access
Published: Nov 2018
26 citations
26 citations
1771 days before retraction
miR-381 induces sensitivity of breast cancer cells to doxorubicin by inactivation of MAPK signaling via FYN
Hailong Mi, Xiaochun Wang, Fang Wang et al. (8 authors)
European Journal of Pharmacology
Published: Sep 2018
28 citations
28 citations
1832 days before retraction
Dual regulatory role of CCNA2 in modulating CDK6 and MET‐mediated cell‐cycle pathway and EMT progression is blocked by miR‐381‐3p in bladder cancer
Jiangfeng Li, Yufan Ying, Haiyun Xie et al. (12 authors)
The FASEB Journal
Open Access
Published: Aug 2018
69 citations
69 citations
1866 days before retraction
Chlorogenic-induced inhibition of non-small cancer cells occurs through regulation of histone deacetylase 6
Hongtao Liu, Xiaoqi Guo, Junni Liu et al. (6 authors)
Cellular and Molecular Biology
Open Access
Published: Jul 2018
12 citations
12 citations
1890 days before retraction
Oncogene-induced regulation of microRNA expression: Implications for cancer initiation, progression and therapy
Athanasios R. Paliouras, Tiziana Monteverde, Michela Garofalo
Cancer Letters
Published: Feb 2018
36 citations
36 citations
2049 days before retraction
Quick Stats
Total Citations:
17
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025